Wiser Hospital for Women and Infants - UMMC
Return to Locations Search
Address:
2500 N. State St.
Jackson, MS 39216
Contact Us:
(601) 984-1000
Parking:
Directions:
From North State Street, turn onto campus from the stoplight at University Drive. Turn right; at the stop sign, turn left to continue on University Drive. Parking Garage B is on the right.
Our Care Specialties at this location:
Our Providers who practice at this location:
| Provider | Specialty Keywords | ||||||||
|---|---|---|---|---|---|---|---|---|---|
|
Practice Locations:
|
baby, infant, pediatric newborn services, childrens newborn services, children's newborn services, newborn, children newborn services, nicu, neonatal | ||||||||
|
Practice Locations:
|
baby, infant, pediatric newborn services, childrens newborn services, children's newborn services, newborn, children newborn services, nicu, neonatal, children neonatal medicine, infant, pediatric neonatal medicine, childrens neonatal medicine, nicu, children's neonatal medicine, newborn | ||||||||
|
Practice Locations:
|
baby, infant, pediatric newborn services, childrens newborn services, children's newborn services, newborn, children newborn services, nicu, neonatal | ||||||||
|
Practice Locations:
|
|||||||||
Angelle L. Klar, MDSpecialties:
Newborn Services, Children's Palliative Medicine, Palliative Care, Complex Care, Neonatal Medicine
View Practice Locations
Practice Locations:
|
baby, infant, pediatric newborn services, childrens newborn services, children's newborn services, newborn, children newborn services, nicu, neonatal, childrens palliative medicine, pediatric palliative medicine, end of life care, terminal care, hospice, children palliative medicine, hospice, end of life, childrens complex care, children's complex care, children complex care, pediatric complex care, palliative, children neonatal medicine, infant, pediatric neonatal medicine, childrens neonatal medicine, nicu, children's neonatal medicine, newborn | ||||||||
|
Practice Locations:
|
baby, infant, pediatric newborn services, childrens newborn services, children's newborn services, newborn, children newborn services, nicu, neonatal | ||||||||
Melissa A. McNaull, MDSpecialties:
Children's Cancer and Blood Disorders, Children's Hematology/Oncology
View Practice Locations
Practice Locations:
|
tumor, leukemia, sickle cell, cancer and blood, soft tissue, pediatric cancer and blood disorders, blood, chemotherapy, oncology, oncologist, childrens cancer and blood disorders, radiation, bone marrow, children cancer and blood disorders, neuroblastoma, cancer, oncology, leukemia, pediatric hematology, children's hematology, oncologist, children hematology/oncology, neuroblastoma, pediatric oncology, children's oncology, pediatric hematology/oncology, hematology, hematologist, childrens hematology/oncology | ||||||||
|
Practice Locations:
|
baby, infant, pediatric newborn services, childrens newborn services, children's newborn services, newborn, children newborn services, nicu, neonatal, children neonatal medicine, infant, pediatric neonatal medicine, childrens neonatal medicine, nicu, children's neonatal medicine, newborn | ||||||||
|
Practice Locations:
|
ob gyn, pregnant, obstetrician, MFM, maternal, high risk pregnancy, gestational diabetes, amniocentesis, preeclampsia, fetal, ultrasound | ||||||||
|
Practice Locations:
|
ob gyn, pregnant, obstetrician, MFM, maternal, high risk pregnancy, gestational diabetes, amniocentesis, preeclampsia, fetal, ultrasound | ||||||||
|
Practice Locations:
|
|||||||||
|
Practice Locations:
|
|||||||||
|
Practice Locations:
|
baby, infant, pediatric newborn services, childrens newborn services, children's newborn services, newborn, children newborn services, nicu, neonatal | ||||||||
|
Practice Locations:
|
surgery, childrens general surgery, pediatric general surgery, children general surgery | ||||||||
|
Practice Locations:
|
pediatric cardio, pediatric abnormal heart beat, congenital heart failure, pediatric ekg, fetal arrhythmia, children's cardio, pediatric cardiac surgery, pediatric interventionalist, cardiology, children's cardiac, murmur, congenital cardiologist, pediatric cardiac, pediatric passing out, fetal cardiac, pediatric heart failure, fetal heart, pediatric mri, kid heart, children cardiology, cardiac, pediatric echocardiogram, pediatric hypertension, pediatric arrhythmia, pediatric palpitations, pediatric interventional, congenital, pediatric heart transplant, pediatric heart, congenital cardiology, baby heart, fetal cardiologist, congenital cardiac, cardiomyopathy, pediatric chest pain, pediatric cardiology, kid cardiac, heart, childrens cardiology, children's heart, pediatric heart problem, pediatric syncope, chf, cardio, pediatric fatigue, pediatric electrophysiologist, pediatric electrophysiology, pediatric high blood pressure, baby heart, pediatric fetal cardiology, fetus, childrens fetal cardiology, children's fetal cardiology, children fetal cardiology | ||||||||
|
Practice Locations:
|
pediatric cardio, pediatric abnormal heart beat, congenital heart failure, pediatric ekg, fetal arrhythmia, children's cardio, pediatric cardiac surgery, pediatric interventionalist, cardiology, children's cardiac, murmur, congenital cardiologist, pediatric cardiac, pediatric passing out, fetal cardiac, pediatric heart failure, fetal heart, pediatric mri, kid heart, children cardiology, cardiac, pediatric echocardiogram, pediatric hypertension, pediatric arrhythmia, pediatric palpitations, pediatric interventional, congenital, pediatric heart transplant, pediatric heart, congenital cardiology, baby heart, fetal cardiologist, congenital cardiac, cardiomyopathy, pediatric chest pain, pediatric cardiology, kid cardiac, heart, childrens cardiology, children's heart, pediatric heart problem, pediatric syncope, chf, cardio, pediatric fatigue, pediatric electrophysiologist, pediatric electrophysiology, pediatric high blood pressure, baby heart, pediatric fetal cardiology, fetus, childrens fetal cardiology, children's fetal cardiology, children fetal cardiology | ||||||||
|
Practice Locations:
|
baby, infant, pediatric newborn services, childrens newborn services, children's newborn services, newborn, children newborn services, nicu, neonatal | ||||||||
|
Practice Locations:
|
baby, infant, pediatric newborn services, childrens newborn services, children's newborn services, newborn, children newborn services, nicu, neonatal |
Our Clinical Trials offered at this location:
Researchers at UMMC are committed to discovering innovative ways to prevent and treat the diseases that affect our daily lives. Clinical research studies play a vital role in the advancement of medicine and can improve the well-being of our families, friends, communities, and future generations. In this way, participation in clinical research studies furthers our vision to create "a healthier Mississippi."
Partnering with UMMC’s researchers may have many advantages, including:
- Gaining access to investigational treatments
- Increasing knowledge about your own health
- Giving the gift of improved health to our communities and future generations
- Contributing to the advancement of science by helping researchers learn more about how the human body and mind work or by helping find a cure or better treatments for diseases
| Clinical Trials | Publish Date | Description | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated with Uterine Fibroids in Premenopausal WomenIRB Number: 2020-0023
Published: April 07, 2020
View Locations
Clinical Trial Locations:
|
20200407093323 |
The purpose of this study is to determine how effective and safe the daily use of a particular medicine (Elagolix) helps postmenopausal women who have heavy menstrual bleeding due to fibroids. women's health M16-824 Sherrina Dixon sbouldin Women's Health |
||||||||||||
A randomized, double blind, parallel-group, placebo controlled study to evaluate the efficacy and safety of IBP-9414 in premature infants 500-1500g birth weight in the prevention of necrotizing enterocolitis - The Connection StudyIRB Number: 2019-0139
Published: June 24, 2019
View Locations
Clinical Trial Locations:
|
20190624155427 |
To evaluate the efficacy of IBP-9414 vs. placebo on the prevention of necrotizing enterocolitis
and on sustained feeding tolerance in very low birth weight premature infants, as well as the
safety of IBP-9414 vs. placebo. The study is powered on the necrotizing enterocolitis endpoint. pediatrics IBP-9414-020 Sandra Tyler mfamuyide Pediatrics |
||||||||||||
A Study of Atezolizumab Versus Placebo Administered in Combination with Paclitaxel, Carboplatin, and Bevacizumab to Patients with Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerIRB Number: 2017-0109
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528152643 |
The purpose of this study is to research the effects, good or bad of Ateozolizumab on ovarian, fallopian tube, or primary peritoneal cancer. <br> women's health;cancer GOG 3015/YO39523 Jennifer Barnes mridgway Cancer Women's Health |
||||||||||||
A Study of the Efficacy and Safety of DigiFab in Antepartum Subjects with Severe PreeclampsiaIRB Number: 2017-0110
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528133159 |
This study will test the effect and safety of Digifab in pregnant women with severe preeclampsia. <br> women's health 2017-0110 Sheila Belk rmorris Women's Health |
||||||||||||
Antihypertensive Therapy for Mild Chronic Hypertension during Pregnancy: A Pragmatic Multicenter Randomized Trial (CHAP)IRB Number: 2017-0094
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528133220 |
This study will evaluate the safety and benefits of treating mild chronic hypertension (CHTN) with blood pressure (BP) medicines during pregnancy. <br> women's health 2017-0094 Sheila Belk sbelk Women's Health |
||||||||||||
DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare TumorsIRB Number: 2017-0152
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528150138 |
This is a study for rare cancers for which there is no standard of care or that has become worse with treatment. The purpose of this study is to determine what good and/or bad effects the combination of the study drugs, ipilimumab and nivolumab, have in the treatment of rare cancers and cancers of unknown primary origin.<br> women's health;cancer S1609 Jennifer Barnes kjeanes Cancer Women's Health |
||||||||||||
Effects of an Exclusive Human Milk Diet on Enteral Feeding Outcomes of Neonates with Congenital Gastrointestinal DisordersIRB Number: 2019-0131
Published: August 26, 2019
View Locations
Clinical Trial Locations:
|
20190826142052 |
This study will identify whether an exclusive human milk diet (EHMD) would improve outcomes in patients with congenital gastrointestinal disorders (CGD) by facilitating an earlier transition off of parental nutrition (PN) when compared to the current standard of a partial human milk or exclusive formula diets. pediatrics;women's health Human Milk Diet/CGD Chelsea Giachelli abhatt Digestive Conditions Pediatrics Women's Health |
||||||||||||
Medical Optimization & Management of Pregnancies with Overt Type 2 Diabetes (MOMPOD)IRB Number: 2016-0225
Published: May 28, 2019
View Locations
Clinical Trial Locations:
|
20190528133210 |
To compare the safety and efficacy of insulin versus insulin plus metformin for treatment of T2DM complicating pregnancy.<br> women's health MOMPOD001v18.5FDA IND (125594) Venessia Johnson kwallace2 Women's Health |
||||||||||||
MK-1242-035: A Pivotal Phase 3 Randomized, Placebo-controlled Vericiguat Outcomes Study in HFrEF (VICTOR)IRB Number: 2021V0793
Published: March 02, 2022
View Locations
Clinical Trial Locations:
|
20220302112702 |
This study is testing MK-1242 (vericiguat) in people with a certain type of heart failure. It will compare MK-1242 to placebo (inactive substance) when added to your existing heart failure treatment. You, your study doctor and the study staff won't know what study drug you are getting. MK-1242 is experimental. heart health;victor;mk-1242 MK-1242-035 Will Pierce lpapadimitriou Heart Health |
||||||||||||
NRG-GY018: A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab (MK-3475, NSC #776864) in Addition to Paclitaxel and Carboplatin for Measurable Stage III or IVA, Stage IVB or Recurrent Endometrial CancerIRB Number: 2019-0227
Published: June 15, 2022
View Locations
Clinical Trial Locations:
|
20220615123907 |
<div>The purpose of this study is to see how well the combination of pembrolizumab, paclitaxel and carboplatin works compared with paclitaxel and carboplatin alone in treating patients with endometrial cancer that is stage III or IV, or has come back (recurrent).</div> gy018;endometrial cancer;pembrolizumab NRG GY0018 Cameronne Dodd kjeanes Cancer |
||||||||||||
Pharmacokinetics of Understudied Drugs Administered to Children per Standard of CareIRB Number: 2018-0115
Published: June 28, 2019
View Locations
Clinical Trial Locations:
|
20190628101637 |
This study will collect information about how various drugs affect children/young adults. The information collected will help develop a standard of care for prescribing drugs in this age group. pediatrics NICHD-2011-POP01 Lacy Malloch jmajure Pediatrics |
||||||||||||
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in older Adults (PREVENTABLE)IRB Number: 2020V0312
Published: January 15, 2021
View Locations
Clinical Trial Locations:
|
20210115100959 |
<span style="color: #000000; font-family: &quot;Source Sans Pro&quot;, &quot;Helvetica Neue&quot;, Helvetica, Roboto, Arial, sans-serif; font-size: 14px; background-color: #ffffff;">PREVENTABLE is a multi-center, randomized, parallel group, placebo-controlled superiority study. Participants will be randomized 1:1 to atorvastatin 40 mg or placebo. This large study conducted in community-dwelling older adults without cardiovascular disease (CVD) or dementia will demonstrate the benefit of statins for reducing the primary composite of death, dementia, and persistent disability and secondary composites including mild cognitive impairment (MCI) and cardiovascular events.</span><div><span style="color: #000000; font-family: &quot;Source Sans Pro&quot;, &quot;Helvetica Neue&quot;, Helvetica, Roboto, Arial, sans-serif; font-size: 14px; background-color: #ffffff;"><br></span></div> cardiac;heart;men's health;women's health;obesity;nutrition PREVENTABLE Theresa Hutson mehall Heart Health Women's Health |
||||||||||||
Premature Infants Receiving Milking or Delayed Cord Clamping: Randomized Controlled Multicenter Non-Inferiority Trial: PREMOD2IRB Number: 2019-0159
Published: November 25, 2019
View Locations
Clinical Trial Locations:
|
20191125100657 |
This study will compare the incidence of long-term neurodevelopmental outcomes at 24 months in premature infants receiving umbilical cord milking (UCM) to those receiving delayed cord clamping (DCC). pediatrics;women's health 1612901 Sandra Tyler skaram Pediatrics Women's Health |
||||||||||||
Randomized, Controlled, Multi-Center Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients with Retinopathy of PrematurityIRB Number: 2020-0010
Published: April 08, 2020
View Locations
Clinical Trial Locations:
|
20200408154611 |
This study will access the safety and effectiveness of aflibercept compared to laser in patients with Retinopathy of Prematurity (ROP). eyes/vision;pediatrics VGFTe-ROP-1920 Sandra Tyler dshakti Eyes/Vision Pediatrics |
||||||||||||
Safety of Sildenafil in Premature Infants at Risk of Bronchopulmonary DysplasiaIRB Number: 2019-0108
Published: August 22, 2019
View Locations
Clinical Trial Locations:
|
20190822150258 |
This trial will study the safety and effectiveness of sildenafil in premature infants who are at risk of developing bronchopulmonary dysplasia (BPD). pediatrics;lungs NICHD-2015-SIL02 Chelsea Giachelli skaram Lungs/Breathing Pediatrics |